Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released May 8, 2014, after the close
10-Q filed May 8, 2014, 38 days after period end · 0001299130-14-000031
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Revenue | $11.64M | $5.58M | $10.04M | $270.00K |
| Net Income | -$18.89M | -$21.10M | -$27.58M | -$34.81M |
| EPS Diluted | -$0.28 |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.37 |
| -$0.50 |
| -$0.66 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
